What the YODA study means for global diabetes care
When type 1 diabetes is not autoimmuneYODA study reveals most African youth with type 1 diabetes lack autoimmune markers—challenging global diagnostic standards.
> Read more
Global perspectives on diabetes
Apply filters
Focus on current practice and emerging trends in diabetes care and complications, with interdisciplinary reporting on clinical management, technology and treatment, including nutrition and lifestyle modification. We’re not limited to the lab or office—learn about pregnancy and diabetes in Southern India, diabetes camps in the Philippines and kidney-pancreas transplantations in Argentina.
More than 1.1 billion adults worldwide live with intermediate hyperglycaemia
Intermediate hyperglycaemia, from warning to opportunityBy 2050, one in eight adults globally will be living with early warning signs of diabetes.
> Read more-
Mexico has implemented a digital lifestyle programme offering insights into how care can be delivered in a more continuous, personalised, and accessible way. -
A pilot programme underway in Egypt addresses a critical gap: many children with type 1 diabetes lack access to the tools and supplies.
-
Small countries should not be viewed as epidemiological outliers, but rather as early warning systems that provide valuable insight into how conditions develop and evolve within populations.
Do you like what you see?
Subscribe to our e-alerts.